Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial.

Front Pharmacol · 2022 · PMC8940304 · PMID 35330830

Europe PMC DOI

hedged sentence

0.3600

closest p · 7.2× alpha

0.3600

boldest claim

The sentences

did not reach statistical significancep = 0.36not close (p > 0.1)

Differences in 28-days mortality rates did not reach statistical significance between the control and neostigmine arms ( p = 0.36).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.